Cargando…
Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery
OBJECTIVE: To investigate the effect of intravitreal injection of triamcinolone acetonide and conbercept on the efficacy and safety of diabetic macular edema (DME) after cataract intraocular lens (IOL) surgery. METHODS: A total of 350 patients with cataract complicated with diabetic macular edema in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159890/ https://www.ncbi.nlm.nih.gov/pubmed/35664937 http://dx.doi.org/10.1155/2022/5606343 |
_version_ | 1784719157148778496 |
---|---|
author | Tang, Bin Wang, Xiaoxuan Luo, Yi Li, Zhi He, Yannan |
author_facet | Tang, Bin Wang, Xiaoxuan Luo, Yi Li, Zhi He, Yannan |
author_sort | Tang, Bin |
collection | PubMed |
description | OBJECTIVE: To investigate the effect of intravitreal injection of triamcinolone acetonide and conbercept on the efficacy and safety of diabetic macular edema (DME) after cataract intraocular lens (IOL) surgery. METHODS: A total of 350 patients with cataract complicated with diabetic macular edema in our hospital from January 2017 to July 2021 were randomly divided into conbercept group and triamcinolone acetonide group. Patients in the conbercept group were given intravitreal injection of conbercept during IOL surgery, and patients in the triamcinolone acetonide group were given injection of triamcinolone acetonide during surgery. RESULTS: Three months after treatment, the best-corrected visual acuity of the two groups was significantly higher than before, the corrected visual acuity of the conbercept group was more significant than the triamcinolone acetonide group, and the intraocular pressure of the triamcinolone acetonide group was higher than the conbercept group. The foveal thickness and macular volume were significantly reduced in both groups, and was reduced more in the conbercept group than in the triamcinolone acetonide group. The contents of VEGF, SDF-1, and IL-6 in both groups were significantly decreased, and the decrease was more significant in the conbercept group than in the triamcinolone acetonide group. The patients with elevated intraocular pressure, headache and vomiting, orbital swelling pain, eye swelling pain, and eye pain in the triamcinolone acetonide group were significantly higher than those in the conbercept group (P < 0.05). CONCLUSIONS: Conbercept and triamcinolone acetonide has a good therapeutic effect on DME in pseudophakic eyes after cataract IOL surgery, which can reduce the degree of macular edema and improve the visual function. However, the therapeutic effect of injection therapy with conbercept is safe, the prognosis is better, and the complication rate is low. |
format | Online Article Text |
id | pubmed-9159890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91598902022-06-02 Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery Tang, Bin Wang, Xiaoxuan Luo, Yi Li, Zhi He, Yannan Evid Based Complement Alternat Med Research Article OBJECTIVE: To investigate the effect of intravitreal injection of triamcinolone acetonide and conbercept on the efficacy and safety of diabetic macular edema (DME) after cataract intraocular lens (IOL) surgery. METHODS: A total of 350 patients with cataract complicated with diabetic macular edema in our hospital from January 2017 to July 2021 were randomly divided into conbercept group and triamcinolone acetonide group. Patients in the conbercept group were given intravitreal injection of conbercept during IOL surgery, and patients in the triamcinolone acetonide group were given injection of triamcinolone acetonide during surgery. RESULTS: Three months after treatment, the best-corrected visual acuity of the two groups was significantly higher than before, the corrected visual acuity of the conbercept group was more significant than the triamcinolone acetonide group, and the intraocular pressure of the triamcinolone acetonide group was higher than the conbercept group. The foveal thickness and macular volume were significantly reduced in both groups, and was reduced more in the conbercept group than in the triamcinolone acetonide group. The contents of VEGF, SDF-1, and IL-6 in both groups were significantly decreased, and the decrease was more significant in the conbercept group than in the triamcinolone acetonide group. The patients with elevated intraocular pressure, headache and vomiting, orbital swelling pain, eye swelling pain, and eye pain in the triamcinolone acetonide group were significantly higher than those in the conbercept group (P < 0.05). CONCLUSIONS: Conbercept and triamcinolone acetonide has a good therapeutic effect on DME in pseudophakic eyes after cataract IOL surgery, which can reduce the degree of macular edema and improve the visual function. However, the therapeutic effect of injection therapy with conbercept is safe, the prognosis is better, and the complication rate is low. Hindawi 2022-05-25 /pmc/articles/PMC9159890/ /pubmed/35664937 http://dx.doi.org/10.1155/2022/5606343 Text en Copyright © 2022 Bin Tang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tang, Bin Wang, Xiaoxuan Luo, Yi Li, Zhi He, Yannan Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title | Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title_full | Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title_fullStr | Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title_full_unstemmed | Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title_short | Efficacy and Safety of Intravitreal Injection of Triamcinolone Acetonide and Conbercept for Intraocular Lens after Cataract Surgery |
title_sort | efficacy and safety of intravitreal injection of triamcinolone acetonide and conbercept for intraocular lens after cataract surgery |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159890/ https://www.ncbi.nlm.nih.gov/pubmed/35664937 http://dx.doi.org/10.1155/2022/5606343 |
work_keys_str_mv | AT tangbin efficacyandsafetyofintravitrealinjectionoftriamcinoloneacetonideandconberceptforintraocularlensaftercataractsurgery AT wangxiaoxuan efficacyandsafetyofintravitrealinjectionoftriamcinoloneacetonideandconberceptforintraocularlensaftercataractsurgery AT luoyi efficacyandsafetyofintravitrealinjectionoftriamcinoloneacetonideandconberceptforintraocularlensaftercataractsurgery AT lizhi efficacyandsafetyofintravitrealinjectionoftriamcinoloneacetonideandconberceptforintraocularlensaftercataractsurgery AT heyannan efficacyandsafetyofintravitrealinjectionoftriamcinoloneacetonideandconberceptforintraocularlensaftercataractsurgery |